Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171520-18-000067
Filing Date
2018-02-08
Accepted
2018-02-08 12:58:14
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS VERWALTUNGS GMBHRHO MANAGEMENT VENTURES IV, L.L.C.RHO VENTURES IV GMBH & CO BETEILIGUNGS KGRHO VENTURES IV HOLDINGS LLCRHO VENTURES IV QP, L.P.RHO VENTURES IV, L.P.

Document Format Files

Seq Description Document Type Size
1 eps7754.htm SC 13G/A 123428
  Complete submission text file 0001171520-18-000067.txt   125335
Mailing Address 124 DUNE RD QUOGUE NY 11959
Business Address 124 DUNE ROAD QUOGUE NY 11959
RHO VENTURES IV QP LP (Filed by) CIK: 0001126022 (see all company filings)

EIN.: 061581537 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Subject) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88750 | Film No.: 18584614
SIC: 2834 Pharmaceutical Preparations